Sirigen Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $64M

Sirigen General Information

Description

Developer of novel polymeric materials for the life-science and diagnostic industries. The company is the developer of light-harvesting polymeric materials, which offer high sensitivity flourescence (HSF) detection, with applications for drug testing, optimized detection techniques and developing next-generation diagnostic tools.

Contact Information

Website
www.sirigen.com
Formerly Known As
Citiweb Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Brightwater House
  • Market Place
  • Ringwood BH24 1AP
  • England, United Kingdom
+44 020
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Becton, Dickinson and Company
Vertical(s)
Corporate Office
  • Brightwater House
  • Market Place
  • Ringwood BH24 1AP
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sirigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 27-Aug-2012 $64M Completed Generating Revenue
8. Later Stage VC 17-Feb-2012 Completed Generating Revenue
7. Later Stage VC (Series G) 13-Oct-2011 Completed Generating Revenue
6. Later Stage VC (Series F) 13-Nov-2010 Completed Generating Revenue
5. Later Stage VC (Series E) 09-Aug-2010 Completed Generating Revenue
4. Later Stage VC (Series D) 20-Apr-2010 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Jun-2009 Completed Generating Revenue
2. Later Stage VC (Series B) 30-Apr-2008 $5.4M $5.4M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Mar-2006 Completed Product Development
To view Sirigen’s complete valuation and funding history, request access »

Sirigen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
To view Sirigen’s complete cap table history, request access »

Sirigen Patents

Sirigen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2015163718-A Novel reagents for directed biomarker signal amplification Pending 19-Jan-2010

Sirigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sirigen Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARC InterCapital Venture Capital Minority
IQ Capital Partners Venture Capital Minority
Angel (individual) Minority
Nesta Limited Partner Minority
Oxford Capital Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Sirigen Investments (1)

Sirigen’s most recent deal was a Seed Round with Let's Cram for . The deal was made on 19-Jan-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Let's Cram 19-Jan-2009 Seed Round Educational and Training Services (B2C)
To view Sirigen’s complete investments history, request access »

Sirigen FAQs

  • When was Sirigen founded?

    Sirigen was founded in 2003.

  • Where is Sirigen headquartered?

    Sirigen is headquartered in Ringwood, United Kingdom.

  • What is the size of Sirigen?

    Sirigen has 15 total employees.

  • What industry is Sirigen in?

    Sirigen’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Sirigen a private or public company?

    Sirigen is a Private company.

  • What is the current valuation of Sirigen?

    The current valuation of Sirigen is .

  • What is Sirigen’s current revenue?

    The current revenue for Sirigen is .

  • How much funding has Sirigen raised over time?

    Sirigen has raised $19M.

  • Who are Sirigen’s investors?

    ARC InterCapital, IQ Capital Partners, , Nesta, and Oxford Capital Partners are 5 of 9 investors who have invested in Sirigen.

  • When was Sirigen acquired?

    Sirigen was acquired on 27-Aug-2012.

  • Who acquired Sirigen?

    Sirigen was acquired by Becton, Dickinson and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process